Biomarin Pharmaceutical (BMRN) Q1 2017 Earnings

23FebConfirmed
Q2 2016
Q3 2016
Q4 2016
Q1 2017
-0.68
-0.09
0.49
1.08

Details

Expected EPS
-0.4
Actual EPS
-0.53
Surprise EPS
-0.13
Surprise Percent
+32.5%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.53 per share for Q1 2017.

0 Comments

Share your thoughts